REQUEST A DEMO
Total
USD $0.00
Search more companies

Hs Biotechnology Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Electronic Shopping and Mail-Order Houses
Full name: Hs Biotechnology Sdn. Bhd. Profile Updated: March 31, 2026
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English Download a sample report

Hs Biotechnology Sdn. Bhd. is an enterprise in Malaysia, with the main office in Shah Alam. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on October 12, 2018. The company’s latest financial report indicates a net sales revenue increase of 15.66% in 2024. Its’ total assets recorded a growth of 80.66%. In 2024, Hs Biotechnology Sdn. Bhd.’s net profit margin decreased by 1.67%.

Headquarters
33-Gf, Jalan Setia Perdana Be, U13/Be,Bandar Setia Alam
Shah Alam; Selangor; Postal Code: 40170

Contact Details: Purchase the Hs Biotechnology Sdn. Bhd. report to view the information.

Basic Information
Financial Auditors:
Purchase the Hs Biotechnology Sdn. Bhd. report to view the information.
Incorporation Date:
October 12, 2018
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Hs Biotechnology Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
15.66%
Total Operating Revenue
15.66%
Operating Profit
-34.38%
Net Profit/Loss for the Period
-41.19%
Total Assets
80.66%
Total Equity
54.63%
Operating Profit Margin
-1.81%
Net Profit Margin
-1.67%
Return on Equity (ROE)
-26.23%
Quick Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?